Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)

SHA:603392 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,340	2,388	3,819	5,193	1,416	710.67
Short-Term Investments	1,250	480	-	-	200	52.54
Trading Asset Securities	1,539	2,510	2,055	2,009	40.39	50.36
Cash & Short-Term Investments	5,128	5,378	5,874	7,201	1,656	813.57
Cash Growth	-6.77%	-8.44%	-18.43%	334.83%	103.56%	134.46%
Accounts Receivable	1,755	2,064	2,999	3,960	2,277	711.6
Other Receivables	156.62	35.96	48.71	5.15	12.45	13.04
Receivables	1,912	2,104	3,053	3,970	2,292	724.64
Inventory	831.26	863.19	905.48	869.14	593.17	400.04
Other Current Assets	120.47	29.44	469.42	139.4	105.2	39.54
Total Current Assets	7,992	8,375	10,302	12,180	4,647	1,978
Property, Plant & Equipment	3,540	3,538	2,641	2,235	1,703	790.98
Long-Term Investments	1,162	1,362	12.01	911.3	61.3	211.3
Other Intangible Assets	821.43	512.46	508.28	292.5	289.92	226.66
Long-Term Deferred Tax Assets	272.44	243.33	157.95	66.01	68.97	56.49
Long-Term Deferred Charges	211.08	363.85	214.29	172.37	27.18	27.76
Other Long-Term Assets	371.81	294.67	1,879	372.3	249.09	212.7
Total Assets	14,371	14,689	15,715	16,230	7,046	3,504
Accounts Payable	470.8	137.94	234.28	275.47	154.08	107.29
Accrued Expenses	169.49	915.89	1,653	2,572	1,541	440.8
Short-Term Debt	120.59	103.62	81.14	140.14	235.64	77.66
Current Portion of Long-Term Debt	93.62	65.68	87.19	3.07	-	-
Current Portion of Leases	-	38.43	13.3	13.73	13.93	-
Current Income Taxes Payable	14.34	8.59	7.49	99.02	146.55	4.37
Current Unearned Revenue	90.17	48.15	70.38	82.28	70.3	40.92
Other Current Liabilities	914.98	693.76	523.42	299.34	204.64	157.98
Total Current Liabilities	1,874	2,012	2,670	3,485	2,366	829.03
Long-Term Debt	102.31	94.19	115.36	102.49	4.9	-
Long-Term Leases	56.6	80.97	12.36	18.43	32.59	-
Long-Term Unearned Revenue	64.72	54.2	33.65	41.37	76.44	94.26
Long-Term Deferred Tax Liabilities	-	-	-	17.15	-	-
Other Long-Term Liabilities	-	-	-	-	3.8	-
Total Liabilities	2,098	2,241	2,831	3,665	2,483	923.29
Common Stock	1,265	1,265	1,268	906.07	607.04	433.6
Additional Paid-In Capital	3,140	3,139	3,312	3,729	445.83	446.27
Retained Earnings	7,777	7,950	8,250	7,906	3,413	1,674
Treasury Stock	-92.17	-92.17	-129.42	-200.17	-	-
Total Common Equity	12,089	12,263	12,701	12,341	4,466	2,554
Minority Interest	183.69	185.16	183.06	223.63	96.2	26.73
Shareholders' Equity	12,273	12,448	12,884	12,565	4,562	2,580
Total Liabilities & Equity	14,371	14,689	15,715	16,230	7,046	3,504
Total Debt	373.11	382.91	309.35	277.86	287.06	77.66
Net Cash (Debt)	4,755	4,995	5,565	6,923	1,369	735.91
Net Cash Growth	-8.94%	-10.23%	-19.63%	405.71%	86.03%	125.74%
Net Cash Per Share	3.64	3.76	4.42	5.54	1.11	0.62
Filing Date Shares Outstanding	1,265	1,265	1,268	1,268	1,232	1,232
Total Common Shares Outstanding	1,265	1,265	1,268	1,268	1,232	1,232
Working Capital	6,118	6,363	7,632	8,695	2,281	1,149
Book Value Per Share	9.56	9.69	10.01	9.73	3.62	2.07
Tangible Book Value	11,268	11,750	12,192	12,049	4,176	2,327
Tangible Book Value Per Share	8.91	9.29	9.61	9.50	3.39	1.89
Buildings	-	779.65	724.87	628.89	392.67	253.3
Machinery	-	1,764	1,510	1,185	666.87	565.97
Construction In Progress	-	1,469	814.56	720.51	924.38	231.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.